References
- J of Korean Medical Association v.38 Statistics of diseases that are five major causes of death of Korean Kim JS
- J of Lipid Res v.31 Dietary influence on serum lipids and lipoproteins Grundy SM;Denke MA
- Lancet v.336 Can lifestyle change reverse coronary heart diseases? Ornish D;Brown SE;Scherwitz LW;Billings JH;Amstrong WT
- Nutrition therapy for CAD Beak IK
- Circ Res v.33 Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins Krauss RM;Herbert PN;Levy RI;Fredrickson DS
- Biochem Biophys Res Commun v.46 Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein Brown WV;Baginsky ML
- FEBS Lett v.65 Effect of serum and C-apoproteins from very low density lipoprotein on human post-heparin plasma hepatic lipase Kinnunen PK;Ehnholm C
- J Biol Chem v.255 Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat Windler E;Chao Y;Havel RJ
- J Clin Invest v.65 Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat Shelburne F;Hanks J;Meyers W;Quarfordt S
- Physiol Rev v.68 Apolipoprotein genetic variation and human diseases Breslow J
- Proc Natl Acad Sci v.90 An apoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3'-untranslated region polymorphisms Dammerman M;Sandkuijl LA;Halaas JL;Chung W;Breslow JL
- J Clin Invest v.96 Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia Li WW;Dammerman MM;Smith JD;Metzger J;Breslow JL;Leff T
- Arterioscler Thromb Vasc Biol v.17 Common genomic variation in the Apo C3 promoter associated with variation in plasma lipoproteins Rovert AH;PhilIp WC;Anthony JGH;Fang S;Stewart BH;Bernard Z
- Korean J of Lipidology v.3 Apolipoprotein E isoforms influence on the distribution of human plasma cholesterols and apolipoproteins Lee MS
- Korean J Nutrition v.31 no.9 Effects of apo E polymorphism and dietary aounseling on the levels of plasma lipids in hyperlipidemic patients Kim SJ;Choue RW;Yim JE;Kim YS
- Guideline for hyperlipidemia therapy Committee for estabilishment of hyperlipidemia therapy guide
- Adv Lipid Res v.6 Practical methods for plasma lipoprotein analysis Hatch FT;Lees RS
- Circulation v.82 An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence Holme I
- Adv Lipid Res v.6 A colorimetric method for estimating serum triglycerides Fletcher MJ
- J Lipid Res v.11 Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions Brnstein M;Scholnick HR;Mortin R
- Clin Chem v.33 Quantification of two different types of apolipoprotein AI containing lipoprotein particle in plasma by enzyme linked differential antibody immunosorvent assay Keren R;Puchois P;Alanpovic P;Fesmine J;Kandoussi A;Fruchart JC
- J of Chrom v.617 Modification of a high-performance lipid chromatographic method for assay of homocysteine in human plasma Phillip EC;Sarah LM;William HV
- Am J Cardiol v.77 Hypertriglyceridermia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men Assmann G;Schulte H;von Eckardstein A
- Am J Cardiol v.70 Regulation of high density lipoprotein cholesterol and triglyceridesto incidence of atheroschlerotic coronary artery disease(the PROCAM experience) Assmann G;Schulte H
- Am J Clin Nutr v.27 Quantitative effects of dietary fat on serum cholesterol in man Hegsted DM;McGandy RB;Myers ML;Stare FJ
- J Clin Invest v.47 Effects of diet on hepatic triglyceride synthesis Fallon HJ;Kemp EL
- The 9th symposium of Korean lipid association Effect of change in dietary intake in risk factor and death of atherosclerosis Suh I;Oh KW
- Atherosclerosis Thrombasis & Vascular Biology v.17 no.2 Lipoprotein lipid response to the national cholesterol education program step II diet by hypercholestrolmia and combined hyperlipidemic women and men Waldon CE;Retzlaff BM;Buck BL
- Lancet v.339 Effects on coronary artery disease of lipid lowering diet, or diet plus cholestyramine. in the St. Thomas. Atherosclerosis Regression Study(STARS) Watts GF;Lewis B;Brunt JNH;Lewis ES;Coltart DJ;Smith LDR;Mann JI;Swan AV
- Survey of national nutrition Department of Hygiene and welfare
- J Cardiovasc Pharmacol v.28 no.4 Effect of a reduced-fat diet with or without pravastatin on glucose tolerance and insulin sensitivity in patients with primary hyperhcolesterolemia Galvan AQ;Natalil A;Baldi S;Frascerra S;Sampietro T;Galetta F;Seghieri G;Ferrannini E
- J Clin Invest v.79 Heterogeneith of cholesterol homeostasis in man:response to change in dietary fat quality and cholesterol quantity McNamara DJ;Kolb R;Paker TS
- J Clin Invest v.76 Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster: association with hypertriglyceridemia Rees A;Stocks J;Sharpe CR;Vella MA;Shoulders CC;Katz J;Jowett NI;Barelle FE;Galton DJ
- Clin Chem v.35 Strong association of single nucleotide substitution in the 3'-untranslated region of the apolipoprotein-C-III gene with common hypertriglyceridemia in Arabs Tas S
- J Biol Chem v.269 Overexpression of human apolipoprotein CIII in transgenic mice results in an accumulation of apolipoprotein B-48 remnants that is corrected by excess apolipoprotein E Silva HV;Lauer SJ;Wang J;Sinonet WS;Weisgraber KH;Mahley RW;Taylor JM
- Science v.249 Hypertriglyceridemia as a result of human apolipoprotein CIII gene expression in transgenic mice Ito Y;Azrolan N;O'Connell A;Walsh A;Breslow JL
- Am J Cardiol 15 v.86 no.8 Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia Kawashirir M;Kajiname K;Nohara A;Yagi K;Inazu A;Koizumi J;Mabuchi H